Pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites undergoing therapeutic paracentesis

Journal of Hepatology

Volumn 25, Issue 3, 1996, Pages 329-333

  Terg, Ruben ^a,d   Miguez, Carlos D ^a   Castro, Lilian ^a   Araldi, Hector ^b   Dominguez, Silvia ^b   Rubio, Modesto ^c  

^a Unidad de Hepatologia   (Argentina)

^b Laboratorio Roux Ocefa   (Argentina)

^c Instituto de Investigaciones Farmacologicas   (Argentina)

^d Unidad de Hepatología   (Argentina)

Author keywords

Ascites; Cirrhosis; Dextran 70; Paracentesis; Pharmacokinetics

Indexed keywords

DEXTRAN 70;

ADULT; AGED; ALCOHOLISM; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPOVOLEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; PARACENTESIS; PRIORITY JOURNAL;

EID: 0030248913     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80119-X     Document Type: Article

References (24)

1. Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jimenez W, Mastai R, Gaya J, Rodes J. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology. 93:1987;234-241.
2. Tito L, Gines P, Arroyo V, Planas R, Panes J, Rimola A, Llach J, Humbert P, Badalamenti S, Jimenez W, Rodes J. Total paracentesis associated with intravenous albumin in the management of patients with cirrhosis and ascites. Gastroenterology. 98:1990;146-151.
3. Salerno F, Badalamenti S, Incerti P, Tempini S, Restelli B, Bruno S, Bellati G, Roffi L. Repeated paracentesis and i.v. albumin infusion to treat "tense" ascites in cirrhotic patients: a safe alternative therapy. J Hepatol. 5:1987;102-108.
4. Gines P, Tito L, Arroyo V, Planas R, Vives J, Tones M, Humbert P, Rimola A, Llach J, Badalamenti L, Jimenez W, Gaya J, Rodes J. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 94:1988;1493-1502.
5. Fassio E, Terg R, Landeira G, Abecasis R, Salemne M, Podesta A, Rodriguez P, Levi D, Kravetz D. Paracentesis with Dextran-70 vs. paracentesis with albumin in cirrhosis with tense ascites. J Hepatol. 14:1992;310-316.
6. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of Haemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology. 13:1991;707-713.
7. Sola R, Vila MC, Andreu M, Oliver MI, Coll S, Gana J, Ledesma S, Gines P, Jimenez W, Arroyo V. Total paracentesis with Dextran-40 vs. diuretic in the treatment of ascites in cirrhosis: a randomized controlled study. J Hepatol. 20:1994;282-288.
8. Planas R, Gines P, Arroyo V, Llach J, Panes J, Vargas V, Salmeron J, Gines A, Toledo C, Rimola A, Jimenez W, Asbert M, Gasull A, Rodes J. Dextran-70 vs. albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study Gastroenterology; 99: 1736-44.
9. WaIkley J, Tillman J, Bonnar J. The persistence of Dextran-70 in blood plasma following its infusion during surgery for prophylaxis against thromboembolism. J Pharm Pharmacol. 28:1976;29-31.
10. Arturson G, Wallenius G. The intravascular persistence of Dextran of different molecular sizes in normal humans. Scand J Clin Lab Invest. 1:1964;76-80.
11. Shumaker R. PKCALC-Basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabol Rev. 17:1986;331-348.
12. Allen L, Kimura K, MacKichaw J, Ritschel W. ACCP nomenclature report. J Clin Pharmacol. 22:1982;215-235.
13. Klotz U, Kroemer H. Clinical pharmacokinetic considerations in the use of plasma expanders. Clin Pharmacokinet. 12:1987;123-135.
14. Arturson G, Granath K, Thoren L, Wallenius G. The renal excretion of low molecular weight dextran. Acta Chir Scand. 127:1964;543-551.
15. Kohler H, Zschiedrich H, Linfante A, Appel F, Pitz H, Clasen R. Die Elimination von Hydroxyathylstarke 200 -0.5, Dextran-40 und Oxypolygelatine. Klin Wochenschr. 60:1982;293-301.
16. Mesmer K. Plasma substitutes. Tinker J, Rapin M. Care of Critically Ill Patients. 1983;569-575 Springer-Verlag, New York.
17. Aberg B, Bloom WL, Hannson E. Gastrointestinal excretion of dextran C14. Acta Physiol Scand. 52:1961;188-194.
18. Wilkinson P, Mendenhall CL. Serum albumin turnover in normal subjects and patients with cirrhosis measured by 131-I-labelled human albumin. Clin Sci. 25:1963;281-292.
19. Boyer JL, Maddrey WC, Baju A, Iber F. The source of albumin in the thoracic duct lymph in patients with portal hypertension and ascites. Am J Med Sci. 257:1969;32-43.
20. Simon D, McCain J, Bonkovsky H, Wells J, Hartle D, Galambos J. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology. 7:1987;423-429.
21. Panos M, Moore K, Vlaviaons P, Chamberg J, Anderson J, Gimson A, Slater J, Rees L, Westaby D, Williams R. Single, total paracentesis for tense ascites, sequential hemodynamics changes and right atrial size. Hepatology. 11:1990;662-667.
22. Terg R, Romero G, Berreta J, Abecasis R, Boerr L. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. A safe and inexpensive option. Dig Dis Sci. 37:1992;79-83.
23. Comparison of albumin, Dextran-70 and Hemaccel in the prevention of effective hypovolemia in cirrhotic patients with ascites treated with total paracentesis. A randomized multicenter study. Hepatology. 22:1995;A456.
24. Kohler H, Kirch W, Klein H, Distler A. Plasma volumen bei Dalysepatienten nach Infusion von 500 ml 6% Hydroxyathylstarke 450 / 0.7, 10% Dextran bzw 3.5% isocyanatvernetzter Gelatine. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin. 84:1979;1236-1238.